ÜbersichtsarbeitOpen Access
Emerging concepts in obesity management: focus on glucagon receptor agonist combinations
Drugs in Context · 24.07.2025 · 14 · 1-11
DOI: 10.7573/dic.2025-4-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drugs in Context, online erschienen am 24.07.2025. Verfasst von Sarah L Anderson. Beteiligte Einrichtung: PeerView Institute for Medical Education, New York, NY, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
endocrinologygastric inhibitory polypeptideglucagon-like peptide-1 obesityoverweight
Autor:innen und Institutionen
- PeerView Institute for Medical Education, New York, NY, USA.
Zitieren
APA
Anderson, S. L. (2025). Emerging concepts in obesity management: focus on glucagon receptor agonist combinations. Drugs in Context, 14, 1-11. https://doi.org/10.7573/dic.2025-4-8
Vancouver
Anderson SL. Emerging concepts in obesity management: focus on glucagon receptor agonist combinations. Drugs in Context. 2025;14:1-11. doi:10.7573/dic.2025-4-8
BibTeX
@article{Anderson2025,
author = {Anderson, Sarah L},
title = {Emerging concepts in obesity management: focus on glucagon receptor agonist combinations},
journal = {Drugs in Context},
year = {2025},
volume = {14},
pages = {1--11},
doi = {10.7573/dic.2025-4-8}
}
EUVIMED